National Research Corporation (NRC) has seen its shares surge by 61.8% over the past year, significantly outperforming the industry, which experienced a 19.8% decline. This growth comes amidst strong recurring revenues and the expanding adoption of its AI-enabled healthcare platform. In contrast, competitors like Iron Mountain Incorporated and Recruit Holdings Co., Ltd. have seen share movements of 38% and -15.5%, respectively, during the same period.
NRC operates primarily in the healthcare experience management sector, providing subscription-based solutions that help organizations enhance patient and employee experiences through real-time feedback. As of now, its Total Recurring Contract Value has reached record highs, indicating robust future revenue potential.
Despite its growth, NRC faces challenges including reliance on renewable customer contracts, competitive pressures, and operational risks. The company is currently valued at a trailing 12-month EV/sales ratio of 3.34X, notably lower than the industry average of 6.27X, positioning it as an attractive option for potential investors.
